New insights from rodent models of fatty liver disease
- PMID: 21126212
- PMCID: PMC3118700
- DOI: 10.1089/ars.2010.3749
New insights from rodent models of fatty liver disease
Abstract
Rodent models of fatty liver disease are essential research tools that provide a window into disease pathogenesis and a testing ground for prevention and treatment. Models come in many varieties involving dietary and genetic manipulations, and sometimes both. High-energy diets that induce obesity do not uniformly cause fatty liver disease; this has prompted close scrutiny of specific macronutrients and nutrient combinations to determine which have the greatest potential for hepatotoxicity. At the same time, diets that do not cause obesity or the metabolic syndrome but do cause severe steatohepatitis have been exploited to study factors important to progressive liver injury, including cell death, oxidative stress, and immune activation. Rodents with a genetic predisposition to overeating offer yet another model in which to explore the evolution of fatty liver disease. In some animals that overeat, steatohepatitis can develop even without resorting to a high-energy diet. Importantly, these models and others have been used to document that aerobic exercise can prevent or reduce fatty liver disease. This review focuses primarily on lessons learned about steatohepatitis from manipulations of diet and eating behavior. Numerous additional insights about hepatic lipid metabolism, which have been gained from genetically engineered mice, are also mentioned.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                Comment in
- 
  
  Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease.Antioxid Redox Signal. 2011 Jul 15;15(2):421-4. doi: 10.1089/ars.2011.3897. Epub 2011 May 25. Antioxid Redox Signal. 2011. PMID: 21254858 Free PMC article. Review.
References
- 
    - Ahsan MK. Okuyama H. Hoshino Y. Oka S. Masutani H. Yodoi J. Nakamura H. Thioredoxin-binding protein-2 deficiency enhances methionine-choline deficient diet-induced hepatic steatosis but inhibits steatohepatitis in mice. Antioxid Redox Signal. 2009;11:2573–2584. - PubMed
 
- 
    - Arsov T. Larter CZ. Nolan CJ. Petrovsky N. Goodnow CC. Teoh NC. Yeh MM. Farrell GC. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. Biochem Biophys Res Commun. 2006;342:1152–1159. - PubMed
 
- 
    - Arsov T. Silva DG. O'Bryan MK. Sainsbury A. Lee NJ. Kennedy C. Manji SS. Nelms K. Liu C. Vinuesa CG. de Kretser DM. Goodnow CC. Petrovsky N. Fat aussie—A new Alstrom syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol Endocrinol. 2006;20:1610–1622. - PubMed
 
- 
    - Asano T. Watanabe K. Kubota N. Gunji T. Omata M. Kadowaki T. Ohnishi S. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis. J Gastroenterol Hepatol. 2009;24:1669–1676. - PubMed
 
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
- Full Text Sources
 
        